Answers are grounded in this paper and cite their sources.
Temporary mechanical circulatory support (MCS) is employed to stabilize patients with refractory heart failure as a bridge to decision, recovery, durable ventricular assist device (VAD), or transplantation. Currently, temporary MCS options in pediatrics are limited, with venoarterial extracorporeal membrane oxygenation (VA-ECMO) being a widely used strategy.1 VA-ECMO augments cardiac output and perfusion pressure to promote end-organ recovery; however, these advantages are countered by increased afterload and myocardial wall stress as well as excess morbidity from bleeding, stroke, and limb ischemia.
No takes yet. Share an insight, caveat, or question.
Bouhout et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: